Post sponsored by

MIL OSI Translation. Region: Russian Federation –

27 August 2021, 07:02

Share this

Photo by M. Mishin. Press Service of the Mayor and the Moscow Government

This was achieved thanks to the re-equipment of the pathomorphological departments of the capital’s clinics.

Diagnostics of patients with oncological diseases has become faster and better in Moscow. Last year, the pathology laboratories were reorganized and reequipped in the capital – as a result, the ability to conduct research for the diagnosis and selection of treatment tactics increased by 1.5 times.

“As part of the implementation in Moscow

new standard of cancer care We paid special attention to the availability of all advanced types of laboratory tests for the diagnosis of oncological diseases and the selection of highly effective treatment methods. As a result of the re-equipment of the pathomorphological departments of Moscow clinics, we have the opportunity to organize work according to the most modern standards, shorten the research time and significantly increase the efficiency of diagnostics and subsequent treatment of oncological diseases, including the use of targeted and immune drugs, ”she said Anastasia Rakova, Deputy Mayor of Moscow for Social Development.

According to her, in the first six months of this year, 643 thousand histological, more than 9.7 thousand molecular genetic and almost 97 thousand immunohistochemical studies of malignant tumors were carried out in Moscow. There are almost 1.5 times more such studies than in the same period last year.

“This makes it possible to select the most effective treatment tactics using the most modern medicines. Thus, for patients with oncological diseases, highly effective diagnostics began to be carried out much faster and better, ”the vice-mayor noted.

New, state-of-the-art equipment in the departments and the level of qualifications of specialists allow conducting research to the highest standards. This is confirmed by an external audit of the Federal Center for Quality Control of Immunohistochemical Research.

The new standard of cancer care was approved in Moscow at the end of 2019. Over the past year, its main provisions have been introduced into practice. On the basis of the largest city hospitals, six multidisciplinary oncological centers were organized – they appeared in the hospital No. 57 named after D.D. Pletnev, Clinical Center named after A.S. Loginov, hospital No. 62, hospital named after S.P. Botkin, Hospital No. 40 and Hospital No. 1. Residents of one or two Moscow districts can apply to each of them.

The cancer centers have created a full range of clinical opportunities: diagnostics, surgical treatment, drug therapy, dispensary observation, and more. Thus, all stages of the provision of specialized care are available in one medical organization, and this makes it possible to reduce the time for making a diagnosis, increase its accuracy and start treatment faster.

Each multidisciplinary center has a modern pathology laboratory. In 2019-2020, a large-scale re-equipment of such laboratories took place – more than 300 units of medical equipment were purchased.

EDITOR’S NOTE: This article is a translation. Apologies should the grammar and or sentence structure not be perfect.

MIL OSI Russia News